Skip to main content
Figure 1 | AIDS Research and Therapy

Figure 1

From: Levels of circulating myeloid subpopulations and of heme oxygenase-1 do not predict CD4+ T cell recovery after the initiation of antiretroviral therapy for HIV disease

Figure 1

Prolonged ART results in an increased frequency of classical monocytes. (A) Thawed PBMCs from HIV patients were stained with antibodies recognizing cell-surface and intracellular myeloid markers. Analysis was performed by sequentially gating on live cells, singlets (FSC-A/FSC-H), non-lymphocyte (SSC-A high/FSC-A high), lineage negative (CD3- CD19- CD56-), and HLA-DR and CD11c positive populations. Myeloid cells were further defined by expression of CD14 and CD16 into three subsets (CD14hiCD16-, CD14dimCD16+, and CD14-CD16- cells). Frequencies of CD14hiCD16- classical monocytes (lower right gate), CD14dimCD16+ non-classical monocytes (upper left gate), and CD11c+ CD14-CD16- mDCs (lower left gate) and in relation to the parent myeloid gate were calculated. (B) Column statistics were performed by 1-way ANOVA on patients described in Table 1. Statistical significance is denoted as *p < 0.05, **p < 0.01, and ***p < 0.001. (C) Myeloid subpopulations were measured during pre-ART to post-ART time points from thawed PBMCs of ART-treated subjects (see "pre- ART-suppressed" subjects described in Table 2). Student’s paired t-test was performed and corresponding p values are described.

Back to article page